Medical Properties Trust Inc (MPT)

Name: Medical Properties Trust Inc (MPT) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name MEDICAL PROPERTIES TRUST INC · CIK 0001287865 · NYSE · Real Estate Investment Trusts

Sector Finance & Real Estate
Fiscal year ends Dec 31

For the year ended 2025-12-31, Medical Properties Trust Inc reported revenue of $972.02M. Revenue fell 2.4% from the prior annual period. Over the twelve months to 2026-03-31, revenue was $1.00B.

Key ratios (year ended 2025-12-31)

90.7%

Gross margin (computed)

-28.5%

Net margin

-6.0%

Return on year-end equity

-2.4%

Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-07

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-03-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$1.00B	$972.02M	$995.55M	$871.80M	$1.54B	$1.54B	$1.25B	$854.20M	$784.52M	$704.75M	$541.14M
Cost of Revenue	$106.23M	$90.31M	$74.17M	$110.07M	$167.42M	$101.44M	$30.14M	$168.21M	$84.17M	n/a	n/a
Gross Profit (computed)	$894.05M	$881.72M	$921.38M	$761.73M	$1.38B	$1.44B	n/a	$685.99M	$700.35M	n/a	n/a
Operating Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$485.58M	$341.64M
Depreciation & Amortization	$280.73M	$272.82M	$453.75M	$616.13M	$345.58M	$333.78M	$275.95M	$156.57M	$141.49M	$131.98M	$97.60M
EBITDA	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$617.56M	$439.24M
Net Income	-$125.95M	-$277.05M	-$2.41B	-$556.48M	$902.60M	$656.02M	$431.45M	$374.68M	$1.02B	$289.79M	$225.05M
EPS (Diluted)	n/a	-$0.46	-$4.02	-$0.93	$1.50	$1.11	$0.81	$0.87	$2.76	$0.82	$0.86
Total Assets	$14.76B	$15.00B	$14.29B	$18.30B	$19.66B	$20.52B	$16.83B	$14.47B	$8.84B	$9.02B	$6.42B
Total Liabilities	$10.22B	$10.39B	$9.46B	$10.67B	$11.06B	$12.07B	$9.49B	$7.44B	$4.28B	$5.19B	$3.17B
Long-Term Debt	$9.66B	$9.70B	$8.85B	$10.06B	$10.27B	$11.28B	$8.87B	$7.02B	$4.04B	$4.90B	$2.91B
Shareholders' Equity	$4.55B	$4.61B	$4.83B	$7.63B	$8.59B	$8.45B	$7.34B	$7.03B	$4.56B	$3.84B	$3.25B
Cash & Equivalents	$425.00M	$540.86M	$332.33M	$250.02M	$235.67M	$459.23M	$549.88M	$1.46B	$820.87M	$171.47M	$83.24M
Operating Cash Flow	$216.12M	$230.77M	$245.48M	$505.79M	$739.01M	$811.66M	$617.64M	$494.12M	$449.09M	$362.24M	$263.84M
Share Repurchases	n/a	$23.44M	n/a	n/a	$17.94M	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding	597.72M	597.01M	600.40M	598.99M	597.48M	596.75M	541.42M	517.52M	370.64M	364.42M	320.51M
Dividends Per Share	n/a	$0.33	$0.46	$0.88	$1.16	$1.12	$1.08	$1.02	$1.00	$0.96	$0.91
Weighted Average Diluted Shares	n/a	600.89M	600.25M	598.52M	598.84M	590.14M	530.46M	428.30M	366.27M	350.44M	261.07M
EPS (Basic)	n/a	-$0.46	-$4.02	-$0.93	$1.50	$1.11	$0.81	$0.87	$2.77	$0.82	$0.86

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView